Latest posts by Lancet Global Health (see all)
- [Comment] Achieving equity in maternal health in China: more to be done - Mar. 25, 2017
- [Articles] Progress and challenges in maternal health in western China: a Countdown to 2015… - Mar. 22, 2017
- [Corrections] Correction to 2016; 5: e392–93 - Mar. 17, 2017
- [Articles] Mobile phone-delivered reminders and incentives to improve childhood immunisation… - Mar. 15, 2017
David Osrin and Tim Colbourn (November, 2016)1 uphold a recommendation to restrict use of chlorhexidine to “infants born at home in environments with high neonatal mortality rates” and assert that “Cochrane reviews, a meta-analysis, and these two new trials have not supported an effect after hospital births”. We do not think it is clear how one could come to such a conclusion from the evidence in the cited papers.
Read article here: